Next Article in Journal
Does the Simultaneous Introduction of Several Pharmaceuticals in the Post-Lenalidomide Era Translate to Better Outcomes in Relapse Refractory Multiple Myeloma? Findings from the Real-World Innovation in Multiple Myeloma (REAL IMM) Study
Next Article in Special Issue
Adapting the Fitness Criteria for Non-Intensive Treatments in Older Patients with Acute Myeloid Leukemia to the Use of Venetoclax-Hypomethylating Agents Combination—Practical Considerations from the Real-Life Experience of the Hematologists of the Rete Ematologica Lombarda
Previous Article in Journal
Evaluation of the Aggressive-Variant Prostate Cancer Molecular Signature in Clinical Laboratory Improvement Amendments (CLIA) Environments
Previous Article in Special Issue
Supportive Care in Older Lymphoma Patients to Reduce Toxicity and Preserve Quality of Life
 
 
Review

Article Versions Notes

Cancers 2023, 15(24), 5845; https://doi.org/10.3390/cancers15245845
Action Date Notes Link
article pdf uploaded. 14 December 2023 15:45 CET Version of Record https://www.mdpi.com/2072-6694/15/24/5845/pdf-vor
article pdf uploaded. 14 December 2023 16:12 CET Updated version of record https://www.mdpi.com/2072-6694/15/24/5845/pdf-vor
article xml file uploaded 15 December 2023 03:25 CET Original file -
article xml uploaded. 15 December 2023 03:25 CET Update https://www.mdpi.com/2072-6694/15/24/5845/xml
article pdf uploaded. 15 December 2023 03:25 CET Updated version of record https://www.mdpi.com/2072-6694/15/24/5845/pdf
article html file updated 15 December 2023 03:26 CET Original file https://www.mdpi.com/2072-6694/15/24/5845/html
Back to TopTop